OQS
VTVT icon

Occudo Quantitative Strategies’s vTv Therapeutics VTVT Stock Holding History

Occudo Quantitative Strategies’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-399
Closed -$30K – 942
2020
Q4 		$30K Buy
+399
New +$30.6K 0.01% 626

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Occudo Quantitative Strategies's VTVT Position: Q1 2021 in Review

Occudo Quantitative Strategies sold out of vTv Therapeutics (VTVT) in Q1 2021, closing a stake of 399 shares — an estimated $30K sold.

Occudo Quantitative Strategies first reported a position in VTVT in Q4 2020 and held it in 1 quarter. The position peaked at $30K in Q4 2020. 48 funds tracked by Wall St. Rank hold VTVT as of Q1 2021.

  • Occudo Quantitative Strategies reported no remaining vTv Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 399 vTv Therapeutics shares in Q1 2021, an estimated $30K.
  • Occudo Quantitative Strategies first reported a position in vTv Therapeutics in Q4 2020 and held it in 1 quarter.
  • Occudo Quantitative Strategies's vTv Therapeutics position peaked at $30K in Q4 2020.
  • 48 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2021.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2021, filed 14 May 2021.